Intellia Therapeutics, Inc. (NTLA)
12.55
-0.29
(-2.26%)
USD |
NASDAQ |
Aug 24, 16:00
12.55
0.00 (0.00%)
After-Hours: 19:54
Intellia Therapeutics Total Liabilities (Quarterly) : 129.46M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 129.46M |
| March 31, 2026 | 137.84M |
| December 31, 2025 | 170.73M |
| September 30, 2025 | 176.85M |
| June 30, 2025 | 183.64M |
| March 31, 2025 | 206.24M |
| December 31, 2024 | 319.06M |
| September 30, 2024 | 210.74M |
| June 30, 2024 | 220.47M |
| March 31, 2024 | 223.45M |
| December 31, 2023 | 250.81M |
| September 30, 2023 | 205.94M |
| June 30, 2023 | 218.35M |
| March 31, 2023 | 227.05M |
| December 31, 2022 | 284.53M |
| September 30, 2022 | 259.51M |
| June 30, 2022 | 229.88M |
| March 31, 2022 | 249.03M |
| December 31, 2021 | 254.22M |
| September 30, 2021 | 227.86M |
| June 30, 2021 | 177.43M |
| Date | Value |
|---|---|
| March 31, 2021 | 171.02M |
| December 31, 2020 | 149.25M |
| September 30, 2020 | 128.94M |
| June 30, 2020 | 139.24M |
| March 31, 2020 | 66.99M |
| December 31, 2019 | 64.40M |
| September 30, 2019 | 70.98M |
| June 30, 2019 | 75.58M |
| March 31, 2019 | 80.02M |
| December 31, 2018 | 69.40M |
| September 30, 2018 | 57.96M |
| June 30, 2018 | 60.44M |
| March 31, 2018 | 64.05M |
| December 31, 2017 | 75.64M |
| September 30, 2017 | 73.32M |
| June 30, 2017 | 77.39M |
| March 31, 2017 | 79.38M |
| December 31, 2016 | 89.13M |
| September 30, 2016 | 83.34M |
| June 30, 2016 | 87.02M |
| March 31, 2016 | 14.06M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 318.91M |
| Twist Bioscience Corp. | 226.70M |
| Tenaya Therapeutics, Inc. | 24.13M |
| Moderna, Inc. | 4.20B |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 857.16M |
| Shareholders Equity (Quarterly) | 727.71M |
| Debt to Equity Ratio | 0.1009 |
| Current Ratio | 6.648 |
| Net Debt Paydown Yield | 0.39% |